Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Review.

[1]  M. Tetti,et al.  Aldosterone as a Mediator of Cardiovascular Damage. , 2022, Hypertension.

[2]  E. Boerwinkle,et al.  Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study , 2022, Hypertension.

[3]  M. Reincke,et al.  Long‐term morbidity and mortality in patients with Cushing's syndrome , 2022, Journal of neuroendocrinology.

[4]  S. Carugo,et al.  Effect of long-term antihypertensive therapy on myocardial strain: a meta-analysis , 2022, Journal of hypertension.

[5]  A. Tabarin,et al.  Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors , 2022, Annals of Internal Medicine.

[6]  R. Vasan,et al.  Hypertension-Mediated Organ Damage: Prevalence, Correlates, and Prognosis in the Community , 2021, Hypertension.

[7]  P. Pellikka,et al.  Cardiac Remodeling and Disease Progression in Patients With Repaired Coarctation of Aorta and Aortic Stenosis , 2021, Circulation. Cardiovascular imaging.

[8]  R. D. de Winter,et al.  Cardiovascular Morbidity and Mortality in Adult Patients With Repaired Aortic Coarctation , 2021, Journal of the American Heart Association.

[9]  G. Mancia,et al.  Left ventricular global longitudinal strain in secondary hypertension: A meta-analysis of echocardiographic studies. , 2021, European journal of internal medicine.

[10]  A. Egbe,et al.  Prognostic implications of left heart diastolic dysfunction in adults with coarctation of aorta. , 2021, European heart journal. Cardiovascular Imaging.

[11]  K. Johansen,et al.  Atherosclerotic Renovascular Disease: A KDIGO (Kidney Disease: Improving Global Outcomes) Controversies Conference , 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  L. Lerman,et al.  Renal Revascularization Attenuates Myocardial Mitochondrial Damage and Improves Diastolic Function in Pigs with Metabolic Syndrome and Renovascular Hypertension , 2021, Journal of Cardiovascular Translational Research.

[13]  A. Egbe,et al.  Persistent Hypertension and Left Ventricular Hypertrophy After Repair of Native Coarctation of Aorta in Adults , 2021, Hypertension.

[14]  S. Carugo,et al.  Effect of surgical treatment on myocardial strain in patients with pheochromocytoma and paraganglioma: a mini-review and meta-analysis , 2021, Journal of Endocrinological Investigation.

[15]  P. Dahlqvist,et al.  Prevalence of Nelson’s syndrome after bilateral adrenalectomy in patients with cushing’s disease: a systematic review and meta-analysis , 2021, Pituitary.

[16]  T. Zelinka,et al.  Effect of adrenalectomy on remission of subclinical left ventricular dysfunction in patients with pheochromocytoma: a speckle-tracking echocardiography study , 2021, Endocrine connections.

[17]  C. Zauner,et al.  Acute and life-threatening complications in Cushing's syndrome: prevalence, predictors and mortality. , 2021, The Journal of clinical endocrinology and metabolism.

[18]  Junting Hu,et al.  Acute cardiac complications and subclinical myocardial injuries associated with pheochromocytoma and paraganglioma , 2020, BMC Cardiovascular Disorders.

[19]  L. Lerman,et al.  Renovascular hypertension induces myocardial mitochondrial damage, contributing to cardiac injury and dysfunction in pigs with metabolic syndrome. , 2020, American journal of hypertension.

[20]  A. Egbe,et al.  Predictors of left ventricular reverse remodelling after coarctation of aorta intervention. , 2020, European heart journal cardiovascular Imaging.

[21]  A. Presson,et al.  Implications of Left Ventricular Dysfunction at Presentation for Infants with Coarctation of the Aorta , 2020, Pediatric Cardiology.

[22]  A. Cremer,et al.  [Chronic pheochromocytoma-induced myocardial injuries: What should we expect from modern and classical echocardiographic tools?] , 2020, Annales de cardiologie et d'angeiologie.

[23]  T. Bednarczuk,et al.  Left Ventricular Structural and Functional Alterations in Patients With Pheochromocytoma/Paraganglioma Before and After Surgery. , 2020, JACC. Cardiovascular imaging.

[24]  É. Mousseaux,et al.  Aldosterone-Related Myocardial Extracellular Matrix Expansion in Hypertension in Humans: A Proof-of-Concept Study by Cardiac Magnetic Resonance. , 2020, JACC. Cardiovascular imaging.

[25]  G. Mancia,et al.  Left ventricular mass reduction and hypertrophy regression following renal artery revascularization: a meta-analysis , 2020, Journal of hypertension.

[26]  G. Grassi,et al.  Targeting subclinical organ damage in obstructive sleep apnea: a narrative review , 2020, Journal of Human Hypertension.

[27]  H. Falhammar,et al.  Cardiovascular Manifestations and Complications of Pheochromocytomas and Paragangliomas , 2020, Journal of clinical medicine.

[28]  S. Zacharieva,et al.  Global longitudinal strain as a marker for systolic function in patients with pheochromocytomas. , 2020, Endocrine-related cancer.

[29]  M. Russo,et al.  Cardiomyopathies and Adrenal Diseases , 2020, International journal of molecular sciences.

[30]  K. Pacak,et al.  Pathophysiology and Acute Management of Tachyarrhythmias in Pheochromocytoma: JACC Review Topic of the Week. , 2020, Journal of the American College of Cardiology.

[31]  L. Sechi,et al.  Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. , 2020, Journal of hypertension.

[32]  A. Egbe,et al.  Increased prevalence of left ventricular diastolic dysfunction in adults with repaired coarctation of aorta , 2020, International journal of cardiology. Heart & vasculature.

[33]  T. Zelinka,et al.  Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on endocrine hypertension of the European society of hypertension. , 2020, Journal of hypertension.

[34]  G. Mancia,et al.  Obstructive sleep apnoea syndrome and left ventricular hypertrophy: a meta-analysis of echocardiographic studies. , 2020, Journal of hypertension.

[35]  T. Fukuda,et al.  Impact of percutaneous revascularization on left ventricular mass and its relationship to outcome in hypertensive patients with renal artery stenosis. , 2020, American journal of hypertension.

[36]  M. Litwin,et al.  Systematic and Multidisciplinary Evaluation of Fibromuscular Dysplasia Patients Reveals High Prevalence of Previously Undetected Fibromuscular Dysplasia Lesions and Affects Clinical Decisions , 2020, Hypertension.

[37]  H. Falhammar,et al.  Clinical features, complications, and outcomes of exogenous and endogenous catecholamine‐triggered Takotsubo syndrome: A systematic review and meta‐analysis of 156 published cases , 2020, Clinical cardiology.

[38]  G. Mancia,et al.  Obstructive sleep apnea and cardiac mechanics: how strain could help us? , 2020, Heart Failure Reviews.

[39]  A. Egbe,et al.  Determinants of Left Ventricular Diastolic Function and Exertional Symptoms in Adults With Coarctation of Aorta , 2020, Circulation. Heart failure.

[40]  I. Bancos,et al.  Cardiovascular risk and mortality in patients with active and treated hypercortisolism. , 2020, Gland surgery.

[41]  L. Lerman,et al.  Selective intrarenal delivery of mesenchymal stem cell-derived extracellular vesicles attenuates myocardial injury in experimental metabolic renovascular disease , 2020, Basic Research in Cardiology.

[42]  A. Wagenmakers,et al.  Decreased Aerobic Exercise Capacity After Long-Term Remission From Cushing Syndrome: Exploration of Mechanisms , 2019, The Journal of clinical endocrinology and metabolism.

[43]  C. Hung,et al.  Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score–Matching Follow‐Up Study With Tissue Doppler Imaging , 2019, Journal of the American Heart Association.

[44]  M. Russo,et al.  Primary aldosteronism-associated cardiomyopathy: Clinical-pathologic impact of aldosterone normalization. , 2019, International journal of cardiology.

[45]  Yan Li,et al.  Left atrial myocardial dysfunction in patients with primary aldosteronism as assessed by speckle-tracking echocardiography. , 2019, Journal of hypertension.

[46]  H. Falhammar,et al.  Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome , 2019, Endocrine.

[47]  J. Kaski,et al.  Takotsubo syndrome's pathophysiology: still a mystery? , 2019, European heart journal.

[48]  I. Bryngelsson,et al.  Overall and Disease-Specific Mortality in Patients With Cushing Disease: A Swedish Nationwide Study. , 2019, The Journal of clinical endocrinology and metabolism.

[49]  M. Aronovitz,et al.  Distinct Phenotypes Induced by Three Degrees of Transverse Aortic Constriction in Mice , 2019, Scientific Reports.

[50]  K. Omata,et al.  3T MRI evaluation of regional catecholamine-producing tumor-induced myocardial injury , 2019, Endocrine connections.

[51]  T. Zelinka,et al.  Catecholamines Induce Left Ventricular Subclinical Systolic Dysfunction: A Speckle-Tracking Echocardiography Study , 2019, Cancers.

[52]  Aditya M. Sharma,et al.  First International Consensus on the diagnosis and management of fibromuscular dysplasia , 2019, Vascular medicine.

[53]  S. McCartney,et al.  Hypercoagulability and Risk of Venous Thromboembolic Events in Endogenous Cushing's Syndrome: A Systematic Meta-Analysis , 2019, Front. Endocrinol..

[54]  Yan Li,et al.  Speckle-Tracking Echocardiographic Layer-Specific Strain Analysis on Subclinical Left Ventricular Dysfunction in Patients With Primary Aldosteronism , 2018, American journal of hypertension.

[55]  H. Köstler,et al.  Increased myocardial sodium signal intensity in Conn’s syndrome detected by 23Na magnetic resonance imaging , 2018, European heart journal cardiovascular Imaging.

[56]  F. Kober,et al.  Cushing Syndrome Is Associated With Subclinical LV Dysfunction and Increased Epicardial Adipose Tissue. , 2018, Journal of the American College of Cardiology.

[57]  F. Moeller,et al.  Stress Cardiomyopathy Diagnosis and Treatment: JACC State-of-the-Art Review. , 2018, Journal of the American College of Cardiology.

[58]  K. Pacak,et al.  Catecholamine-Induced Cardiomyopathy in Pheochromocytoma: How to Manage a Rare Complication in a Rare Disease? , 2018, Hormone and Metabolic Research.

[59]  G. Curhan,et al.  Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism , 2018, JAMA cardiology.

[60]  A. Januszewicz,et al.  Echocardiographic assessment of left ventricular morphology and function in patients with fibromuscular dysplasia: the ARCADIA-POL study , 2018, Journal of hypertension.

[61]  Jeroen J. Bax,et al.  International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management , 2018, European heart journal.

[62]  Jeroen J. Bax,et al.  International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology , 2018, European heart journal.

[63]  C. Zoccali,et al.  Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term , 2018, Hypertension.

[64]  G. Curhan,et al.  Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. , 2018, The lancet. Diabetes & endocrinology.

[65]  Fiorenzo Gaita,et al.  Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. , 2018, The lancet. Diabetes & endocrinology.

[66]  S. Albert,et al.  Pheochromocytoma as a reversible cause of cardiomyopathy: Analysis and review of the literature. , 2017, International journal of cardiology.

[67]  G. Mancia,et al.  Renal artery stenosis and left ventricular hypertrophy: an updated review and meta-analysis of echocardiographic studies , 2017, Journal of Hypertension.

[68]  F. Gao,et al.  Cardiovascular phenotype in Smad3 deficient mice with renovascular hypertension , 2017, PloS one.

[69]  C. Brizard,et al.  Elevated sympathetic activity, endothelial dysfunction, and late hypertension after repair of coarctation of the aorta. , 2017, International journal of cardiology.

[70]  G. Gielerak,et al.  Cushing’s Disease: Subclinical Left Ventricular Systolic and Diastolic Dysfunction Revealed by Speckle Tracking Echocardiography and Tissue Doppler Imaging , 2017, Front. Endocrinol..

[71]  A. Sarybaev,et al.  Right Ventricular Remodeling and Dysfunction in Obstructive Sleep Apnea: A Systematic Review of the Literature and Meta-Analysis , 2017, Canadian respiratory journal.

[72]  Allan Klein,et al.  A Test in Context: Myocardial Strain Measured by Speckle-Tracking Echocardiography. , 2017, Journal of the American College of Cardiology.

[73]  S. Tsagarakis,et al.  Cardiac hypertrophy in Cushing’s syndrome: if not hypertension then what? , 2017, Endocrine.

[74]  P. Rossignol,et al.  Renal Artery Stenosis in Patients with Resistant Hypertension: Stent It or Not? , 2017, Current Hypertension Reports.

[75]  T. Zelinka,et al.  Long-Term Effect of Adrenalectomy on Cardiovascular Remodeling in Patients With Pheochromocytoma , 2016, The Journal of clinical endocrinology and metabolism.

[76]  Y. Ishikawa,et al.  Pathology and molecular mechanisms of coarctation of the aorta and its association with the ductus arteriosus , 2017, The Journal of Physiological Sciences.

[77]  F. Veglio,et al.  Left ventricular geometry and 24-h blood pressure profile in Cushing’s syndrome , 2017, Endocrine.

[78]  A. Tabarin,et al.  Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. , 2016, European journal of endocrinology.

[79]  Niki Karavitaki,et al.  Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study. , 2016, The lancet. Diabetes & endocrinology.

[80]  M. Robson,et al.  Pheochromocytoma Is Characterized by Catecholamine-Mediated Myocarditis, Focal and Diffuse Myocardial Fibrosis, and Myocardial Dysfunction. , 2016, Journal of the American College of Cardiology.

[81]  M. Rojas,et al.  Effects of Restoration of Blood Flow on the Development of Aortic Atherosclerosis in ApoE−/− Mice With Unilateral Renal Artery Stenosis , 2016, Journal of the American Heart Association.

[82]  A. Papagianni,et al.  To intervene or not? A man with multidrug-resistant hypertension, endovascular abdominal aneurysm repair, bilateral renal artery stenosis and end-stage renal disease salvaged with renal artery stenting , 2016, Blood pressure.

[83]  M. Russo,et al.  Atrogin-1 Pathway Activation in Cushing Syndrome Cardiomyopathy. , 2016, Journal of the American College of Cardiology.

[84]  K. Kuck,et al.  Differential diagnosis of a fulminant myocarditis: the pheochromocytoma crisis , 2015, European heart journal. Acute cardiovascular care.

[85]  J. Lusson,et al.  Acute and Chronic Pheochromocytoma-Induced Cardiomyopathies: Different Prognoses? , 2015, Medicine.

[86]  Martin Reincke,et al.  Subclinical hypercortisolism: a state, a syndrome, or a disease? , 2015, European journal of endocrinology.

[87]  P. Kalra,et al.  Risks for mortality and renal replacement therapy in atherosclerotic renovascular disease compared with other causes of chronic kidney disease , 2015, Nephrology.

[88]  M. Gadelha,et al.  Adverse effects of glucocorticoids: coagulopathy. , 2015, European journal of endocrinology.

[89]  L. Lerman,et al.  Paradigm Shifts in Atherosclerotic Renovascular Disease: Where Are We Now? , 2015, Journal of the American Society of Nephrology : JASN.

[90]  O. Dekkers,et al.  Management of endocrine disease: Mortality remains increased in Cushing's disease despite biochemical remission: a systematic review and meta-analysis. , 2015, European journal of endocrinology.

[91]  A. Januszewicz,et al.  Determinants of concentric left ventricular hypertrophy in patients with resistant hypertension: RESIST-POL study , 2015, Hypertension Research.

[92]  P. Śliwiński,et al.  Factors associated with diastolic dysfunction in patients with resistant hypertension: resist-POL study. , 2015, American journal of hypertension.

[93]  P. Kalra,et al.  Revascularisation of renal artery stenosis as a therapy for heart failure: an observational cohort study , 2015, The Lancet.

[94]  R. Topor-Madry,et al.  Independent association of obstructive sleep apnea with left ventricular geometry and systolic function in resistant hypertension: the RESIST-POL study. , 2014, Sleep medicine.

[95]  P. Chanson,et al.  Cardiac Structure and Function in Cushing's Syndrome: A Cardiac Magnetic Resonance Imaging Study , 2014, The Journal of clinical endocrinology and metabolism.

[96]  P. Gallego,et al.  Pulmonary hypertension in young adults with repaired coarctation of the aorta: an unrecognised factor associated with premature mortality and heart failure. , 2014, International journal of cardiology.

[97]  P. Kilner,et al.  Prevalence and prognostic implication of restenosis or dilatation at the aortic coarctation repair site assessed by cardiovascular MRI in adult patients late after coarctation repair. , 2014, International journal of cardiology.

[98]  R. Golfieri,et al.  Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study. , 2014, The lancet. Diabetes & endocrinology.

[99]  Ralph B D'Agostino,et al.  Stenting and medical therapy for atherosclerotic renal-artery stenosis. , 2014, The New England journal of medicine.

[100]  L. Lerman,et al.  Cardiac function in renovascular hypertensive patients with and without renal dysfunction. , 2014, American journal of hypertension.

[101]  F. Veglio,et al.  Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. , 2013, The Journal of clinical endocrinology and metabolism.

[102]  P. Filardi,et al.  Cardiovascular involvement in patients affected by acromegaly: an appraisal. , 2013, International journal of cardiology.

[103]  P. Plouin,et al.  Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study , 2013, Hypertension.

[104]  A. Hagège,et al.  Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma , 2013, Heart.

[105]  A. Pessina,et al.  Long-Term Control of Arterial Hypertension and Regression of Left Ventricular Hypertrophy With Treatment of Primary Aldosteronism , 2013, Hypertension.

[106]  N. Brown.  Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis , 2013, Nature Reviews Nephrology.

[107]  E. Horváth-Puhó,et al.  Multisystem morbidity and mortality in Cushing's syndrome: a cohort study. , 2013, The Journal of clinical endocrinology and metabolism.

[108]  J. Borén,et al.  A mouse model reveals an important role for catecholamine‐induced lipotoxicity in the pathogenesis of stress‐induced cardiomyopathy , 2013, European journal of heart failure.

[109]  J. Toth,et al.  Altered hemodynamics, endothelial function, and protein expression occur with aortic coarctation and persist after repair. , 2012, American journal of physiology. Heart and circulatory physiology.

[110]  J. Connell,et al.  Demonstration of Blood Pressure-Independent Noninfarct Myocardial Fibrosis in Primary Aldosteronism: A Cardiac Magnetic Resonance Imaging Study , 2012, Circulation. Cardiovascular imaging.

[111]  R. Holle,et al.  Observational Study Mortality in Treated Primary Aldosteronism: The German Conn's Registry , 2012, Hypertension.

[112]  M. Allessie,et al.  Aldosterone promotes atrial fibrillation. , 2012, European heart journal.

[113]  R. Wachter,et al.  Impact of obstructive sleep apnoea on diastolic function , 2012, European Respiratory Journal.

[114]  Yen-Hung Lin,et al.  Contrast‐enhanced MRI index of diffuse myocardial fibrosis is increased in primary aldosteronism , 2012, Journal of magnetic resonance imaging : JMRI.

[115]  T. Zelinka,et al.  High Incidence of Cardiovascular Complications in Pheochromocytoma , 2012, Hormone and Metabolic Research.

[116]  N. Madias,et al.  Hypertension and symptomatic hypokalemia in a patient with simultaneous unilateral stenoses of intrarenal arteries and mesangioproliferative glomerulonephritis. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[117]  G. Parati,et al.  Clinical relevance of cardiac structure and function abnormalities in patients with Cushing’s syndrome before and after cure , 2012, Clinical endocrinology.

[118]  Jeroen J. Bax,et al.  Increased myocardial fibrosis and left ventricular dysfunction in Cushing's syndrome. , 2012, European journal of endocrinology.

[119]  F. Messerli,et al.  Takotsubo-like cardiomyopathy in pheochromocytoma. , 2011, International journal of cardiology.

[120]  P. Dabadghao,et al.  Cardiovascular dysfunction and catecholamine cardiomyopathy in pheochromocytoma patients and their reversal following surgical cure: results of a prospective case-control study. , 2011, Surgery.

[121]  Mark E. Anderson,et al.  Oxidation of CaMKII determines the cardiotoxic effects of aldosterone , 2011, Nature Medicine.

[122]  J. Lenders,et al.  Cardiovascular manifestations of phaeochromocytoma , 2011, Journal of hypertension.

[123]  H. Makani,et al.  Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering syndrome. , 2011, European heart journal.

[124]  P. Jones,et al.  Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. , 2011, The Journal of clinical endocrinology and metabolism.

[125]  G. de Simone,et al.  Does Information on Systolic and Diastolic Function Improve Prediction of a Cardiovascular Event by Left Ventricular Hypertrophy in Arterial Hypertension? , 2010, Hypertension.

[126]  Alberto Fernández,et al.  Prevalence of pituitary adenomas: a community‐based, cross‐sectional study in Banbury (Oxfordshire, UK) , 2010, Clinical endocrinology.

[127]  Jeroen J. Bax,et al.  Cardiac dysfunction is reversed upon successful treatment of Cushing's syndrome. , 2010, European journal of endocrinology.

[128]  A. Mihailidou,et al.  Glucocorticoids Activate Cardiac Mineralocorticoid Receptors During Experimental Myocardial Infarction , 2009, Hypertension.

[129]  N. Dhalla,et al.  Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress-induced heart disease. , 2009, Canadian journal of physiology and pharmacology.

[130]  W. Mali,et al.  Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. , 2009, Annals of internal medicine.

[131]  A. Verbeek,et al.  Metastases but not cardiovascular mortality reduces life expectancy following surgical resection of apparently benign pheochromocytoma. , 2008, Endocrine-related cancer.

[132]  D. Rizzoni,et al.  Inappropriate Left Ventricular Mass in Patients With Primary Aldosteronism , 2008, Hypertension.

[133]  H. Matsubara,et al.  Aldosterone Nongenomically Produces NADPH Oxidase–Dependent Reactive Oxygen Species and Induces Myocyte Apoptosis , 2008, Hypertension Research.

[134]  É. Mousseaux,et al.  Increased central aortic stiffness and left ventricular mass in normotensive young subjects after successful coarctation repair. , 2006, American heart journal.

[135]  L. Sechi,et al.  Long-Term Cardiac Effects of Adrenalectomy or Mineralocorticoid Antagonists in Patients With Primary Aldosteronism , 2007, Hypertension.

[136]  T. Opthof,et al.  Aldosterone modulates If current through gene expression in cultured neonatal rat ventricular myocytes , 2007 .

[137]  Masayoshi Shichiri,et al.  Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system. , 2007, Endocrinology.

[138]  J. Loscalzo,et al.  Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity , 2007, Nature Medicine.

[139]  M. Iida,et al.  Role of aldosterone in left ventricular hypertrophy in hypertension. , 2006, American journal of hypertension.

[140]  R. Foley,et al.  Left ventricular morphology and function in patients with atherosclerotic renovascular disease. , 2005, Journal of the American Society of Nephrology : JASN.

[141]  R. Foley,et al.  Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. , 2005, Kidney international.

[142]  B. Lorell,et al.  Aldosterone directly stimulates cardiac myocyte hypertrophy. , 2004, Journal of cardiac failure.

[143]  Phalla Ou,et al.  Late systemic hypertension and aortic arch geometry after successful repair of coarctation of the aorta. , 2004, European heart journal.

[144]  R. Coleman,et al.  Aldosterone Administration to Mice Stimulates Macrophage NADPH Oxidase and Increases Atherosclerosis Development: A Possible Role for Angiotensin-Converting Enzyme and the Receptors or Angiotensin II and Aldosterone , 2004, Circulation.

[145]  M. Omura,et al.  Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. , 2004, Hypertension research : official journal of the Japanese Society of Hypertension.

[146]  Jeroen J. Bax,et al.  Increased prevalence of regurgitant valvular heart disease in acromegaly. , 2004, The Journal of clinical endocrinology and metabolism.

[147]  M. Muiesan,et al.  Left ventricular structural and functional characteristics in Cushing's syndrome. , 2003, Journal of the American College of Cardiology.

[148]  J. Delyani,et al.  Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. , 2002, Endocrinology.

[149]  D. Celermajer,et al.  Survivors of coarctation repair: fixed but not cured , 2002, Heart.

[150]  Ricardo Rocha,et al.  Aldosterone induces a vascular inflammatory phenotype in the rat heart. , 2002, American journal of physiology. Heart and circulatory physiology.

[151]  J. Steinberger,et al.  Long-term follow-up of patients after coarctation of the aorta repair. , 2002, The American journal of cardiology.

[152]  D. Sawyer,et al.  Adrenergic regulation of cardiac myocyte apoptosis , 2001, Journal of cellular physiology.

[153]  T. Ino,et al.  Restenosis after balloon angioplasty of coarctation: Relationship with ductus arteriosus , 2000, Pediatrics international : official journal of the Japan Pediatric Society.

[154]  H. Rennke,et al.  Printed in U.S.A. Copyright © 2000 by The Endocrine Society Aldosterone: A Mediator of Myocardial Necrosis and Renal Arteriopathy* , 2022 .

[155]  B. Biondi,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Cardiovascular Effects of Short-Term Growth Hormone , 2022 .

[156]  C. Stier,et al.  Downloaded from http://hyper.ahajournals.org / by guest on February 21, 2013Role of Aldosterone in Renal Vascular Injury in Stroke-Prone Hypertensive Rats , 2022 .

[157]  E. Porteri,et al.  Relations between cardiac and vascular structure in patients with primary and secondary hypertension. , 1998, Journal of the American College of Cardiology.

[158]  C. Stier,et al.  Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. , 1998, Hypertension.

[159]  H. Gardiner,et al.  Arterial reactivity is significantly impaired in normotensive young adults after successful repair of aortic coarctation in childhood. , 1994, Circulation.

[160]  G. Chatellier,et al.  Left ventricular mass and geometry before and after etiologic treatment in renovascular hypertension, aldosterone-producing adenoma, and pheochromocytoma. , 1993, American journal of hypertension.

[161]  K. Weber,et al.  Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. , 1993, The American journal of cardiology.

[162]  K. Weber,et al.  Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. , 1992, The Journal of laboratory and clinical medicine.

[163]  R. Erbel,et al.  Arrhythmia profile in acromegaly. , 1992, European heart journal.

[164]  V. Fuster,et al.  Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction. , 1989, Circulation.

[165]  J. Sehested,et al.  Different reactivity and structure of the prestenotic and poststenotic aorta in human coarctation. Implications for baroreceptor function. , 1982, Circulation.